#ACR22 Abstr# Interesting data for IMID patients who had #COVID. A cohort study in Norway (1/3 had RA and mostly on TNFi; 6% RTX) showed greater anti-Spike Ab in 4th vaccine vs 3rd dose. However, the greatest was in those with 3 x doses + COVID infection (Hybrid) @RheumNow https://t.co/hGFSGqJtBT

Benavides-Villanueva et al. Single centre 28 case series of IVIG in AAV. Used due to relapse in 25, concomitant infection in 3. BVAS 0 in 56.5% at month 24, glucocorticoid sparing effect. @RheumNow #ACR22 Abstr#1079 https://t.co/wfg1HSKM9O https://t.co/DuReVU2jA4

• Intravenous Immunoglobulin in Antineutrophil Cytoplasmic Antibody-associated Va…

Abs 0714 at #ACR22 real-world obs study finds seropositive and seronegative RA patients had similar clinical effectiveness 1 year after starting bDMARD or JAKi. @RheumNow https://t.co/UrVgZ0zVno https://t.co/LnXMfOkQIp

• Real-World Treatment Effectiveness of Disease-Modifying Anti-Rheumatic Drugs by…

Early TNFi use and cardiovascular events in AS Abstract #0415 #ACR22 @RheumNow 📍17.6k patients, 91% male, 80% white 📍TNFi initiators were younger with lower prev. of HTN and DM 📍TNFi was associated with higher risk of incident CVD, CVA, and MACE https://t.co/7bCkfk7EYY

I questioned HCQ dose reducing in my recent newsletter & podcast; more evidence! Receiving less HCQ = more damage and more CVD Observational, not clearly causal, but should make you wonder... Are we sure we should be shooting for <5mg/kg/day? #ACR22 @RheumNow #0982 https://t.co/SuAwSumgu1

Abs 0698 at #ACR22 finds that a 20 pack-year or more of cigarette smoking assoc'd w/ a modestly higher risk of incident PMR among women. Yet another reason to encourage smoking cessation in patients. @RheumNow https://t.co/HOVTIPSjOi https://t.co/Akuukxb90Q

• Cohort Study of Cigarette Smoking and the Risk of Developing Polymyalgia Rheuma…

Nettleton @SattuiSEMD @zach_wallace_md @EBRheum et al. PJP prophylaxis in AAV. Incidence PJP 15.9/1000PY. 5/8 who got PJP got prophylaxis. Prophylaxis assoc medication-related adverse events. @RheumNow #ACR22 Abstr#1081 https://t.co/kAD1nRSdPa https://t.co/HjqtW1P6N4

• Incidence of Pneumocystis Jiroveci Pneumonia in Patients with ANCA Vasculitis I…

Banik et al. MTX as induction and maintenance for localised GPA. 48% in remission at 1 year. 39% required RTX. @RheumNow #ACR22 Abstr#1082 https://t.co/Pn8owLgaTj https://t.co/0iEeNuY2JU

• Outcomes of Methotrexate as an Initial Induction and Maintenance Regimen for Lo…

Abstr #0732 utilized #NLP to capture and classify VZV infxn using 2 approaches 1. Bag of Words (BOW) - filtered by vaccine mentions 2. kNN- active vs historical infection - BoW --> 92% accuracy - kNN --> 64% accuracy @RheumNow #ACR22 #NLP

#abst1007 #acr22 We are what we eat. DIPSA RCT of Mediterranean diet& DASH-low caloric diet vs. standard of care as adjunct therapy in PsA w/BMI >25: low sugar & more whole fruit=⬇️PASI&SJC. ⬆️unsaturated than saturated fatty acids= higher enthesitis score. #acrbest @RheumNow https://t.co/cMKdlnJPQc

Roccatello et al. AAV with severe AKI. RTX+CYC+methylpred+no maintenance vs CYC+AZA maintenance. No difference in overall survival, 6-month therapeutic response rate, and 6-, and 12-month functional renal recovery. @RheumNow #ACR22 Abstr#1083 https://t.co/yv12bzwq6x https://t.co/YXUjpSzZ6I

• Treatment of ANCA-associated Vasculitis with Extreme Impairment of Renal Functi…

#abst1012 #acr22 @rheumnow CASIPSA Study of SI CT in 48 PsA pts vs 48 controls. Disease duration 22.87 ± 14.95 y, 43.48 %HLA-B27+. higher prevalences of erosion in PsA (18%) preferentially located on the anterior and middle regions of the SIJs https://t.co/4dtJNCKf4I

axPsA and AS adult pts exhibit different genetic risk factors & serum IL-17 levels. GUS demonstrated significant pharmacodynamic effects and clinical improvement in axPsA and non-axPsA pts. Abs 1038 #ACR22 @RheumNow https://t.co/9Rjw7usO8J

• Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Ankylo…

Updates on Reproductive Health in Women with SLE https://t.co/E09cvQbVoD #ACR22 https://t.co/Ausa6ELoHe

• https://bit.ly/3O5MWaa